MB

Mamta Bansal

Active Director Director DIN 08221474
DIN 08221474 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Mamta Bansal

Data last updated:

Mamta Bansal is a Director at Ess Ess Pharma Private Limited (since 2018). The company operates in Pharma. Ess Ess Pharma Private Limited reported revenue of ₹7.9 Lakh (FY 2025).

DIN 08221474
Primary Designation Director
Industry Pharma
First Appointment 11 Sep 2018
Oldest Company Age 26 yrs
Largest company Ess Ess Pharma Private Limited · ₹7.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ess Ess Pharma Private Limited U24232AS2000PTC006073
Director11 Sep 20182000₹7.9 Lakh (FY 2025)Active

Board colleagues of Mamta Bansal

NameDINCompanyDesignation
Khushal Aditya Bansal09520180Ess Ess Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ess Ess Pharma Private Limited
Premium access

Shareholding and investment profile for Mamta Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Bansal

Mamta Bansal currently holds 1 directorship: Ess Ess Pharma Private Limited (Director, since 11 Sep 2018, revenue ₹7.9 Lakh (FY 2025)).

Mamta Bansal was first appointed on 11 Sep 2018 as Director at Ess Ess Pharma Private Limited.

The current boards of Mamta Bansal's companies include Khushal Aditya Bansal (Ess Ess Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available